Boothbay Fund Management’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Boothbay Fund Management’s Portfolio ROIVW Stock Details ROIVW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-39,010	Closed	-$393K	–	2239
2023 Q2	$393K	Hold	39,010	–	–	0.01%	1200
2023 Q1	$288K	Buy	39,010 +572	+1%	+$1.06K	0.01%	1528
2022 Q4	$307K	Buy	38,438 +8,891	+30%	+$9.74K	0.01%	1377
2022 Q3	$95K	Buy	29,547 +3,495	+13%	+$1.86K	﹤0.01%	2055
2022 Q2	$106K	Buy	26,052 +2,581	+11%	+$1.35K	﹤0.01%	1972
2022 Q1	$116K	Buy	23,471 +6,982	+42%	+$8.87K	﹤0.01%	2064
2021 Q4	$166K	Buy	+16,489	New	+$25.2K	﹤0.01%	1553

Boothbay Fund Management's ROIVW Position: Q3 2023 in Review

Boothbay Fund Management sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q3 2023, closing a stake of 39,010 shares — an estimated $393K sold.

Boothbay Fund Management first reported a position in ROIVW in Q4 2021 and held it in 7 quarters. The position peaked at $393K in Q2 2023. 0 funds tracked by Wall St. Rank hold ROIVW as of Q3 2023.

Boothbay Fund Management reported no remaining Roivant Sciences Ltd. Warrant position as of Q3 2023 after selling out during the quarter.
Boothbay Fund Management sold 39,010 Roivant Sciences Ltd. Warrant shares in Q3 2023, an estimated $393K.
Boothbay Fund Management first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 7 quarters.
Boothbay Fund Management's Roivant Sciences Ltd. Warrant position peaked at $393K in Q2 2023.
0 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q3 2023.

Based on Boothbay Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.